29 March 2017
News and Views
Links and Services
The most recent issue of the Journal of Gastroenterology evaluates the use of protease inhibitors and NSAIDs for the prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis.
Post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis is the most frequent comp
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors